secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001104659-24-035028
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS raises ~$20M in registered direct offering plus warrants priced at $1.535/share
--------------------------------------------------------------------------------

- Gross proceeds of ~$20M from sale of 13,029,316 shares (or pre-funded warrants) at $1.535/share on Nasdaq.
- Concurrent private placement of warrants to purchase up to 13,029,316 shares at $1.41, exercisable for 5.5 years.
- Offering includes warrants exercisable immediately; closing expected March 19, 2024.
- Net proceeds to fund R&D, working capital, and general corporate purposes.
- A.G.P./Alliance Global Partners acting as sole placement agent with 7% cash fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924035028/0001104659-24-035028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924035028/tm248987d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-035028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer